Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects Suffering From Moderate-to-Severe Pain and Burning Upon Urination Associated With Uncomplicated Urinary Tract Infections (uUTI)
Clinical trial NCT01650051 · COMPLETED
Trial details
- NCT number
- NCT01650051
- Sponsor
- Amneal Pharmaceuticals, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2013-02-01
- Enrollment
- 424
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.